SpaceX picks Goldman Sachs to lead record-breaking IPO, sources say

SpaceX is preparing to publicly disclose its IPO prospectus, with Goldman Sachs leading the offering and a syndicate that includes Morgan Stanley, Bank of America, Citigroup and JPMorgan. The company was last valued at $1.25 trillion in February after its merger with xAI, positioning what could be a record-setting listing amid a broader wave of AI-linked mega IPOs. The move could intensify competition for public-market attention versus OpenAI and Anthropic, both valued near $1 trillion by private investors.

Analysis

The immediate winners are the lead-left bookrunner and the syndicate, but the bigger edge is in the downstream cross-sell: a marquee AI-adjacent IPO of this scale typically converts into multi-quarter wallet share gains in equity issuance, convert work, and secondary sell-downs for the same banks. GS should capture the best economics and signaling benefit; MS, BAC, C, and JPM still gain if execution is clean, but the real second-order move is a broader re-rating of the “IPO revival” basket if the deal prints with strong demand and tight guidance.

What matters for public comps is not just one listing, but whether this resets the private-market liquidity discount for frontier AI/space assets. If the book builds with low concessions, it can pull forward timelines for other mega-cap private names and compress the gap between private marks and public multiples, which is bullish for late-stage investors but potentially expensive for public-market buyers. The flip side is that a failed or heavily discounted launch would likely freeze the pipeline for months and punish the entire late-stage VC complex.

The key catalyst window is days to weeks around prospectus release, pricing range, and any signals on insider lockup/secondary supply. The main tail risk is governance and valuation credibility: once the market scrutinizes concentrated control, capital intensity, and path-to-cash-flow, multiple expansion can disappear fast even if the brand is strong. In that scenario, the banks still win on fees, but the broader AI-IPO optimism trade reverses sharply.

The contrarian read is that the market may be overpricing the halo effect while underpricing deal fatigue. A single blockbuster filing does not solve the scarcity of public-market capacity for very large, very long-duration growth stories; if anything, it can expose how much capital is chasing a small set of names, making the first deal a temporary liquidity event rather than a durable regime shift.

Key Decisions for Investors

• Long GS vs. XLF for the next 2-6 weeks: highest direct fee capture and best chance of incremental advisory/ECM wallet-share; stop if the prospectus shows weak demand indicators or the book is cut materially below implied talk.
• Buy a short-dated call spread on NDAQ into the prospectus/pricing window: asymmetric upside if the IPO pipeline narrative broadens, but cap risk because one deal does not guarantee a sustained revival.
• Pair long GS / short a basket of late-stage private-market proxies where valuation reset risk is highest over the next 1-3 months; use if the filing catalyzes a public-vs-private multiple convergence trade.
• Avoid chasing MS/BAC/C/JPM outright; their upside is more muted unless the deal triggers a wave of follow-on issuance. Prefer them only as part of a basket if you want broad syndicate exposure with lower single-name risk.
• If the final terms imply aggressive valuation or heavy insider sell-down, fade the optimism by selling into strength in the underwriting group after pricing, targeting a 3-10 day event-driven move.